Korro Bio, Inc.
KRRO
$6.04
$0.7614.39%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.09M | 1.46M | 2.55M | 2.27M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.09M | 1.46M | 2.55M | 2.27M | -- |
| Cost of Revenue | 10.58M | 18.36M | -- | -- | 12.67M |
| Gross Profit | -9.49M | -16.90M | 2.55M | 2.27M | -12.67M |
| SG&A Expenses | 9.06M | 10.30M | 10.66M | 11.13M | 10.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.33M | 28.66M | 27.57M | 25.31M | 23.29M |
| Operating Income | -19.24M | -27.20M | -25.02M | -23.04M | -23.29M |
| Income Before Tax | -18.06M | -25.77M | -23.39M | -21.10M | -21.01M |
| Income Tax Expenses | -- | 1.00K | -- | 103.00K | -9.00K |
| Earnings from Continuing Operations | -18.06M | -25.77M | -23.39M | -21.20M | -21.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.06M | -25.77M | -23.39M | -21.20M | -21.00M |
| EBIT | -19.24M | -27.20M | -25.02M | -23.04M | -23.29M |
| EBITDA | -18.06M | -25.98M | -23.80M | -21.79M | -22.43M |
| EPS Basic | -1.92 | -2.74 | -2.49 | -2.26 | -2.26 |
| Normalized Basic EPS | -1.20 | -1.72 | -1.56 | -1.41 | -1.41 |
| EPS Diluted | -1.92 | -2.74 | -2.49 | -2.26 | -2.26 |
| Normalized Diluted EPS | -1.20 | -1.72 | -1.56 | -1.41 | -1.41 |
| Average Basic Shares Outstanding | 9.39M | 9.39M | 9.38M | 9.37M | 9.30M |
| Average Diluted Shares Outstanding | 9.39M | 9.39M | 9.38M | 9.37M | 9.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |